Yüksel Ürün/X
Feb 23, 2025, 11:50
Yüksel Ürün: Can biopsy be omitted after a negative MRI in suspected prostate cancer?
Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about a paper by Charlie Hamm et al. published in JAMA Oncology:
“Can biopsy be omitted after a negative MRI in suspected prostate cancer?
- In a 3-year study of 593 men, 48% had negative MRI results – 86% avoided biopsy.
- Only 4% of those monitored developed clinically significant prostate cancer.
- MRI has high negative predictive value, making biopsy omission safe with proper monitoring!”
“Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer”
Authors: Charlie Hamm, Patrick Asbach, Anna Pöhlmann, Frank König, Hannes Cash et al.
More posts featuring Yüksel Ürün.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 26, 2025, 15:47
Mar 26, 2025, 15:07
Mar 26, 2025, 14:53
Mar 26, 2025, 14:43
Mar 26, 2025, 14:26
Mar 26, 2025, 14:11
Mar 26, 2025, 14:01